News and Trends 25 Aug 2022
KU Leuven spin-off AstriVax raises €30M for vaccine platform – first stop, yellow fever
A Belgian university spinoff has generated the biggest seed capital financing in the institution’s history. Closing with €30 million ($30 million), AstriVax will draw on technology developed at the KU…